Poor
Mostly Unaligned
Patient Risk:
Low
Summary
Most statements are about pricing and general contraception duration, which are not supported or addressed by the provided FDA label excerpts. Only statements related to improper insertion/removal, palpation, and REMS/train-the-provider requirements are label-supported.
Category Scores
Accurate Statements
Nexplanon is used for long-term contraception.
No indication/contraception-duration information is present in the provided excerpts (Sections 2.2, 2.3, 5.1, 5.2).
Nexplanon upfront cost includes the implant medication and may also include the insertion procedure (office visit/procedure fee).
Not supported by provided label excerpts (Sections provided do not address cost/billing).
Unsupported Statements
Nexplanon pricing varies widely by country and pharmacy.
The provided prescribing information excerpts do not discuss pricing by country or pharmacy.
Nexplanon out-of-pocket cost depends on whether payment is for the implant only versus also including the clinician’s procedure and insertion/removal visit.
The provided prescribing information excerpts do not discuss patient out-of-pocket cost components or billing structures.
Nexplanon out-of-pocket cost with insurance depends on whether Nexplanon is covered on the plan’s formulary and at what tier.
The provided prescribing information excerpts do not discuss insurance coverage/tiering.
Nexplanon out-of-pocket cost with insurance depends on whether insertion is billed as part of the drug cost or separately as a procedure/office visit.
The provided prescribing information excerpts do not discuss billing categorization or insurance reimbursement.
Nexplanon out-of-pocket cost with insurance depends on deductible status for the year.
The provided prescribing information excerpts do not discuss deductibles.
With insurance, patients typically pay a copay or coinsurance for Nexplanon.
The provided prescribing information excerpts do not discuss typical copay/coinsurance amounts.
Nexplanon is used for long-term contraception.
No indication or duration-of-use information is provided in the supplied label excerpts.
Nexplanon upfront cost includes the implant medication and may also include the insertion procedure (office visit/procedure fee).
The provided prescribing information excerpts do not discuss cost composition.
Removal or replacement later may be billed for Nexplanon planning and is described as not needed at first insertion.
The provided label excerpts provided do not discuss billing for planning or whether planning is or is not needed at first insertion.
Contradictions
Important Omissions
If evaluating insertion/removal-related claims, there is missing specificity that palpation immediately after insertion is required and that undetected improper insertion can lead to unintended pregnancy.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The evaluated statements are largely administrative (pricing) or unsupported by the supplied label excerpts. The only label-relevant safety area in the excerpts concerns improper insertion/removal risks and REMS/training requirements, which are not substantively reflected in the pricing/cost-focused statements.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Unaligned
Primary Issue
Most claims concern pricing/insurance/cost details and contraception duration, none of which are supported by the provided FDA label excerpts.
Suggested Improvement
Limit claims to what the provided label excerpts support (e.g., need for proper subdermal insertion with palpation, risks from improper insertion/removal, REMS availability, and provider training/localization prior to removal of non-palpable implants). Remove or rephrase pricing and insurance/billing statements unless supported by label sections provided.